Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

The point is the reason the stock value has shrunk so much and now below the warrant exercise price is largely a result of Dan O'Connor acting unethically to line his pockets throwing investor interests aside all while executing a weak business strategy that wasted a lot of capital, then when he was finally canned, the extent of his damage was made clear to the market and the Board stood flat footed without a succession plan and put a retiree in as interim CEO for nearly a year which destroyed that much more value. The morally right action would be to extend the warrants because LTSHs who bought warrants long ago are being penalized for management and Board poor and self-serving business decisions.